This study is to evaluate the efficacy of a mobile app for monitoring the quality of life of patients but also on detection delay of side effects and/or complications linked to the therapeutic management. This allow to adapt their care more quickly, through a prospective randomized study. The impact of this connected monitoring of patients' anxiety will also be evaluated in this study as well as the time taken by the medical team to manage alerts generated by this application.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Enrollment
66
patients have to respond different questionnaires about their quality of life on the mobile app. And follow-up visits with the physicians as usual
Follow-up visits with the pysicians as usual
Clinique privée
Marseille, France
RECRUITINGAssessment of the impact of the connected mobile monitoring application on the quality of life, at 6 months, of patients treated for an operated glioma.
The primary outcome measure is the difference in quality of life assessed by the QLQ-BN20 scale at 6 months, compared to inclusion. This scale is made up of 20 items which are grouped into 4 dimensions (future uncertainty, visual disorder, motor dysfunction, and communication deficit) and 7 isolated items.
Time frame: 6 months
Marie-Hélène barba
CONTACT
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.